Please login to the form below

Not currently logged in
Email:
Password:

renal disorders

This page shows the latest renal disorders news and features for those working in and with pharma, biotech and healthcare.

Boehringer signs renal disease research collaboration

Boehringer signs renal disease research collaboration

Boehringer Ingelheim has signed a new research collaboration with Hydra Biosciences that will this time focus on renal diseases and disorders. ... developing strong research partners to discover new treatments for renal disease and related disorders.

Latest news

  • AZ pays $273m for Ardelyx renal disease drug AZ pays $273m for Ardelyx renal disease drug

    AZ pays $273m for Ardelyx renal disease drug. Phase II candidate could tackle fluid overload in kidney and heart disorders. ... accumulation. Ardelyx hopes the drug will be able to tackle fluid overload in kidney and heart disorders such as end-stage

  • Disease area focus: Hepatitis C

    While it has always been regarded as a liver disease, it has also been associated with numerous haematological, renal, dermatological, rheumatic, autoimmune and brain disorders.

  • Mochida and Wyeth in novel vanilloid pain tie-up

    Existing painkillers sometimes cause gastrointestinal disorders or renal disorders, which limits their use.

  • Amgen to buy kidney drug firm Ilypsa for USD 420m

    Ilypsa's focus on renal disorders complements Amgen's existing drug portfolio, which includes Aranesp (darbepoetin alfa) and Epogen (epoetin alfa) artificial versions of human erythropoietin used to treat anaemia in

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics